Related by context. All words. (Click for frequent words.) 74 premorbid 73 neurocognitive function 71 HRQOL 71 HRQL 71 psychiatric comorbidity 70 somatic symptoms 70 HRQoL 70 comorbid depression 69 alexithymia 69 neurocognitive functioning 69 comorbid disorders 69 euthymic patients 69 hyperactivity inattention 68 neuropsychological functioning 68 Depressive symptoms 68 depressive symptoms 68 symptom severity 68 neuropsychological deficits 68 neurocognitive 68 depressive symptomatology 68 nondepressed 68 comorbid anxiety 68 poststroke 67 psychosocial variables 67 psychiatric comorbidities 67 cognitive functioning 67 BMI z 66 hippocampal volume 66 #q# deletion syndrome 66 neurodevelopmental outcome 66 daytime alertness 66 neurocognitive deficits 66 affective psychosis 66 neuromotor 65 QoL 65 SGRQ 65 SRBD 65 affective disorders 65 glucose homeostasis 65 euthymic 65 neurocognitive impairment 65 MMSE scores 65 neurodevelopmental outcomes 65 impaired cognition 65 cognitive affective 65 affective psychoses 65 neurobehavioural 65 hypertension diabetes mellitus 65 sociodemographic characteristics 65 abstinent alcoholics 65 liver histology 65 antioxidant supplementation 65 comorbid 65 tic severity 65 cognitive function 64 sociodemographic variables 64 subscale scores 64 Suicidal ideation 64 autonomic dysfunction 64 poststroke depression 64 adrenal function 64 left ventricular diastolic 64 callous unemotional traits 64 cardiac autonomic 64 sociodemographic factors 64 neuropsychological impairments 64 GH deficiency 64 neurosensory 64 extrapyramidal symptoms 64 APOE genotype 64 T1DM 64 hippocampal volumes 64 neurobehavioral 64 depression suicidal ideation 63 psychiatric morbidity 63 tic disorders 63 shorter telomere length 63 sensory gating 63 subsyndromal 63 habitual snoring 63 carotid IMT 63 depressive symptom 63 Comorbid 63 subclinical atherosclerosis 63 nonpsychotic 63 attention-deficit/hyperactivity disorder ADHD 63 syndromal 63 prefrontal cortical 63 neuro cognitive 63 left ventricular systolic 63 internalizing disorders 63 MMSE score 63 parkinsonian 63 chronicity 63 cognitive domains 63 comorbid psychiatric 63 behavioral disinhibition 63 symptomatology 63 ADCS CGIC 63 neuropsychiatric symptoms 62 meta analytic review 62 hippocampal function 62 serum parathyroid hormone 62 unfavorable cytogenetics 62 Endothelial function 62 MADRS score 62 Cognitive impairment 62 androgen depletion 62 salivary cortisol 62 univariate analyzes 62 attention-deficit/hyperactivity disorder 62 psychomotor 62 psychopathological symptoms 62 hippocampal atrophy 62 daytime somnolence 62 schizotypal 62 inattention hyperactivity 62 hypochondriasis 62 internalizing behaviors 62 ADHD symptoms 62 subscales 62 CPAP adherence 62 WOMAC pain 62 subjective sleepiness 62 HIV lipodystrophy 62 puerperal psychosis 62 haematologic 62 Socioeconomic status 62 familial clustering 62 abnormal lipid 62 neuropathological 61 neurodevelopmental impairment 61 emotional lability 61 MetS 61 serum lipid levels 61 Montgomery Åsberg Depression 61 Sleep disturbances 61 mania hypomania 61 lipid profiles 61 neuropsychological 61 metabolic disturbances 61 hypersomnia 61 intracranial hypertension 61 exploratory endpoints 61 comorbidity 61 multivariate adjustment 61 rCBF 61 PANSS scores 61 dysfunctional voiding 61 neurocognition 61 serum BDNF 61 diabetes mellitus DM 61 schizophreniform disorder 61 cognitive 61 cortisol secretion 61 untreated psychosis 61 externalizing disorders 61 sociodemographics 61 neurological abnormalities 61 Logistic regression analysis 61 psychopathology 61 hypoactive 61 elevated IOP 61 predisposing factor 61 systolic function 61 HPA axis 61 amnestic MCI 61 clinicopathological features 61 CORE OM 61 subthreshold depression 61 neuropsychological assessment 61 comorbid conditions 61 generalized epilepsy 60 antidepressant efficacy 60 subclinical hypothyroidism 60 Sociodemographic 60 pharmacological therapies 60 lipid parameters 60 posttraumatic 60 intelligence quotient IQ 60 ADAS Cog 60 daytime drowsiness 60 venlafaxine XR 60 parkinsonism 60 daytime sleepiness 60 premenopause 60 Heritability 60 dysthymia 60 postoperative AF 60 unipolar depression 60 cardiometabolic risk 60 overactive bladder symptoms 60 white matter hyperintensities 60 proliferative diabetic retinopathy 60 YMRS 60 schizotypal traits 60 hepatic function 60 fasting insulin 60 cortical atrophy 60 Mood disorders 60 EDSS scores 60 posttransplant 60 maladaptive behaviors 60 amygdala reactivity 60 abdominal adiposity 60 attain statistical significance 60 arterial thickening 60 nonobese 60 subthreshold 60 antenatal depression 60 intima media thickness 60 neurodevelopment 60 serum PTH 60 decompensated cirrhosis 60 Neuroticism 60 hyperarousal 60 somatoform disorder 60 extrapyramidal symptoms EPS 60 esophageal motility 60 neurobehavioral functioning 60 CYP#D# genotype 60 platelet activation 60 self directedness 60 neurologic dysfunction 60 mild cognitive 60 non affective psychosis 60 coronary microvascular 60 Erectile function 60 multi infarct dementia 60 thyrotropin levels 60 electroencephalographic 59 cardiorespiratory fitness 59 unmeasured confounders 59 cranial irradiation 59 posttreatment 59 cognitive deficits 59 cognitive impairment 59 bivariate analyzes 59 schizophrenia schizoaffective disorder 59 hypoxemia 59 HIV HCV coinfected 59 vesicoureteral reflux 59 androgen excess 59 dysthymic 59 erection hardness 59 metabolic abnormalities 59 systolic hypertension 59 obstructive CAD 59 neurodevelopmental disability 59 nighttime awakenings 59 maturational 59 nonalcoholic steatohepatitis NASH 59 interpersonal psychotherapy 59 myocardial reperfusion 59 NYHA functional class 59 multivariate analyzes 59 neurologic impairment 59 serum folate concentrations 59 acetabular dysplasia 59 neuro developmental 59 autistic traits 59 neurological sequelae 59 psychomotor retardation 59 APOE ε4 59 Prefrontal 59 UPDRS 59 multivariable analyzes 59 spirometric 59 somatic complaints 59 airway reactivity 59 Cognitive behavioral 59 subsyndromal depression 59 artery stenosis 59 AUDs 59 affective disorder 59 juvenile idiopathic arthritis JIA 59 serum testosterone 59 somatoform disorders 59 atypical neuroleptics 59 Neuropsychological 59 comorbid substance 59 pharmacologic treatments 59 hemiparesis 59 probands 59 suicide attempters 59 akinesia 59 synaptic function 59 hematopoietic cancers 59 Genetic predisposition 59 neurocognitive dysfunction 59 behavioral abnormalities 59 comorbidities 59 serum IGF 59 Frontal lobe 59 df = 59 T2DM 59 cognitive dysfunction 59 depression irritability 59 p = .# [002] 59 HADS 59 androgen deficiency 59 progressive neurologic 59 Chronic pancreatitis 59 physiological arousal 59 Univariate analysis 59 baseline HbA1c 59 hypothalamic pituitary adrenal axis 59 hypoperfusion 59 cerebral oxygenation 59 reflux symptoms 59 underlying pathophysiology 59 hsCRP levels 59 elevated triglyceride levels 59 Socioeconomic factors 59 Testosterone deficiency 59 airway responsiveness 59 pulmonary dysfunction 59 idiopathic Parkinson disease 59 Health Assessment Questionnaire 59 neurologic abnormalities 59 vestibular dysfunction 59 QIDS SR 59 OSAHS 59 gait disturbance 59 somatization disorder 59 Multivariate analyzes 59 neurologic sequelae 59 plasma folate 59 Wernicke Korsakoff syndrome 59 insulin resistance syndrome 59 morbidity mortality 59 attention-deficit/hyperactivity 59 growth hormone secretion 59 diastolic function 59 adenotonsillectomy 59 menstrual irregularity 59 HAMD 59 virological response 59 bulimia nervosa 58 decrements 58 elevated serum creatinine 58 hypercholesterolaemia 58 Genetic variants 58 lesional 58 dopaminergic therapy 58 covariate 58 colorectal adenoma 58 mood dysregulation 58 symptomatic VTE 58 prolactin levels 58 dysthymic disorder 58 hyperkinetic disorder 58 Chronic ITP 58 psychometric properties 58 metabolic dysfunction 58 anhedonia 58 vasomotor 58 ADAS cog 58 hyper IgE syndrome 58 atopic 58 prognostic variables 58 predictive validity 58 PANSS total 58 psychosocial stressors 58 nondemented 58 nonalcoholic steatohepatitis 58 hepatic encephalopathy HE 58 LUTS 58 potentially modifiable 58 acute subacute 58 bronchopulmonary dysplasia BPD 58 cortical activation 58 overt nephropathy 58 lethargy irritability 58 hyperprolactinemia 58 impaired glucose metabolism 58 prosocial behavior 58 dietary calcium intake 58 primary aldosteronism 58 posterior cingulate 58 elevated homocysteine 58 CP CPPS 58 endothelial function 58 metabolic parameters 58 convergent validity 58 renal scarring 58 endophenotypes 58 baroreflex 58 psychologic 58 clinically meaningful reductions 58 mRS 58 familial aggregation 58 potential confounding variables 58 perceptual reasoning 58 serum folate 58 Postoperative 58 fractional anisotropy 58 sociodemographic 58 metabolic abnormality 58 chronic periodontitis 58 logistic regression analyzes 58 multivariable analysis 58 Y BOCS 58 Comorbidity 58 Irritability 58 parkinsonian symptoms 58 dyslipidaemia 58 neuropsychiatric disorder 58 atherothrombotic 58 Mental retardation 58 mortality morbidity 58 amblyopic 58 EQ 5D 58 Brief Psychiatric 58 interrater reliability 58 Anxiety disorders 58 atherogenic dyslipidemia 58 glomerular filtration 58 Daytime sleepiness 58 GABRA2 gene 58 hyperreflexia 58 nocturnal hypoglycemia 58 interindividual variability 58 perioperative complications 58 HDRS 58 VCFS 58 detrusor overactivity 58 coronary calcification 58 NIH CPSI 58 hyperglycaemia 58 vertigo dizziness 58 idiopathic intracranial hypertension 58 hypomanic symptoms 58 maladjustment 58 neuritic 58 interobserver 58 postural stability 58 TF CBT 58 microsatellite instability 58 plasma lipids 58 hormonal abnormalities 58 alanine aminotransferase ALT 58 substance induced psychosis 58 prostate cancer CaP 58 Nicotine dependence 58 HAQ DI 58 Comorbidities 58 serum cortisol 58 antihypertensive therapy 58 Symptom severity 58 neurologic symptoms 58 bone microarchitecture 58 emotional dysregulation 58 morbidities 58 serum estradiol 58 Mild cognitive impairment 58 Exacerbations 58 Severe Primary IGFD 58 neuroleptic 58 function subscale 58 femoral neck fracture 58 elevated ALT 58 Negative Symptoms 58 glycated hemoglobin levels 58 juvenile idiopathic arthritis 57 serum lipid 57 glycosylated hemoglobin HbA1c 57 subscores 57 thyrotropin 57 preoperative PSA 57 postinjury 57 IBDQ 57 neurologic outcomes 57 Personality traits 57 proband 57 mucosal inflammation 57 postnatally 57 esotropia 57 colorectal adenomas 57 Montgomery Asberg Depression 57 mixed hyperlipidemia 57 childhood acute lymphoblastic 57 anemia hemoglobin 57 obesity insulin resistance 57 testicular tumors 57 BMPR2 57 pathophysiological processes 57 neuronal dysfunction 57 Subgroup analysis 57 obstructive sleep 57 obese adolescents 57 plasma cortisol 57 overt hypothyroidism 57 Personality disorders 57 prognostic factors 57 p# activation 57 subcortical 57 oxcarbazepine 57 pharmacological therapy 57 Interpersonal psychotherapy 57 intact parathyroid hormone 57 thrombophilia 57 CONCERTA ® 57 tau pathology 57 premenstrual dysphoric disorder 57 noncognitive 57 hydroxyvitamin D levels 57 Sjögren syndrome 57 neurological impairment 57 DSM IV Axis 57 SGPT 57 elevated cortisol 57 pharmacological interventions 57 acute psychosis 57 Hamilton Rating Scale 57 renal allograft 57 comorbid illnesses 57 limiting generalizability 57 Symptom Checklist 57 malabsorptive 57 intermittent exotropia 57 SNHL 57 nodal metastases 57 GABRA2 57 echocardiographic parameters 57 psychotic symptoms 57 prognostic indicators 57 ELBW 57 kidney allograft 57 normotensive 57 hemodynamics 57 plasma leptin 57 carotid atherosclerosis 57 subscore 57 amnestic mild cognitive impairment 57 BPRS 57 acute mania 57 confusion disorientation 57 visceral adiposity 57 ragweed allergic 57 Visual acuity 57 hypomanic episodes 57 severe hypoglycaemia 57 voiding dysfunction 57 socioeconomic status SES 57 HAM D# 57 HeFH 57 hyperhomocysteinemia 57 behavioral disturbances 57 glycated hemoglobin HbA1c 57 anterior temporal 57 statistically significant predictor 57 micronutrient intake 57 SLC#A# [002] 57 hyperlipidaemia 57 heterozygous familial 57 neurological impairments 57 nonpharmacologic 57 gallstone disease 57 DSM IV diagnosis 57 β = 57 Primary endpoints 57 comorbid psychiatric disorders 57 psychosocial 57 transaminase elevations 57 elevated LDH 57 hyperactive impulsive 57 intermittent hypoxia 57 neurobehavioral disorder 57 subclinical cardiovascular disease 57 cardio metabolic 57 Sleep disordered breathing 57 preterm neonates 57 elevated triglycerides 57 impaired endothelial 57 cortical thinning 57 somatic symptom 57 cognition 57 urate levels 57 pathophysiological mechanisms 57 Neurocognitive 57 causal pathway 57 plasma creatinine 57 cerebral perfusion 57 temporoparietal 57 intravascular hemolysis 57 Child Behavior Checklist 57 nitrotyrosine 57 postoperative complication 57 methotrexate monotherapy 57 Korsakoff syndrome 57 locomotor activity 57 Nonspecific 57 developmental trajectories 57 motor neuropathy 57 lumbar disk herniation 57 Neuropsychiatric Inventory 57 neuropsychological impairment 57 cardio respiratory fitness 57 irritability lethargy 57 Generalized anxiety disorder 57 narcolepsy cataplexy 57 phonological processing 57 pediatric bipolar disorder 57 plasma lipid 57 primary ovarian insufficiency 57 intravenous cyclophosphamide 57 albumin excretion rate 57 amisulpride 57 psychoeducation 57 bacterial prostatitis 57 cerebral atrophy 57 HbA 1c levels 57 obstructive coronary artery 57 methodologic 57 PANSS 57 BPH symptom 57 Heavy menstrual bleeding 57 microvascular dysfunction 57 adiposity 57 pharmacokinetic interaction 57 impulsivity 57 autoregulation 57 post natally 57 metabolite concentrations 57 prefrontal regions 57 diabetic polyneuropathy 57 nonfatal MI 57 urolithiasis 57 serum uric acid 57 neutrophil counts 57 prolactin elevation 56 hyperinsulinemia 56 vasodilatation 56 S. aureus colonization 56 clinicopathological 56 de novo AML 56 oral anticoagulation 56 frequent awakenings 56 Mild Cognitive Impairment 56 Major depressive disorder 56 muscle dysmorphia 56 Calcium intake 56 irritability insomnia 56 Parkinsonian 56 glucose tolerance 56 PNH patients 56 postoperative delirium 56 serum vitamin D 56 mitochondrial toxicity 56 coronary artery atherosclerosis 56 hypercalciuria 56 inflammatory biomarkers 56 Apgar scores 56 autism dyslexia 56 onset diabetes mellitus 56 AST ALT 56 cognitive dysfunctions 56 sub syndromal 56 5 HTTLPR 56 beta blocker therapy 56 diagnosing ADHD 56 lability 56 metabolic syndrome MetS 56 adjunctive placebo 56 biochemical recurrence 56 compensatory mechanisms 56 Unified Parkinson Disease 56 Longitudinal studies 56 cholinergic tone 56 albumin excretion 56 hydroxyvitamin D concentrations 56 abnormal lipids 56 ECOG PS 56 fasting plasma 56 ICD shocks 56 β cell 56 Leydig cell 56 prostate carcinogenesis 56 CHD mortality 56 POAG 56 mood lability 56 adverse perinatal 56 gastrointestinal motility 56 aminotransferase levels 56 hereditary predisposition 56 thyroid dysfunction 56 dysphoric 56 tic disorder 56 renal fibrosis 56 preserved ejection fraction 56 esophageal reflux 56 proliferative retinopathy 56 serum sodium 56 cortical excitability 56 parietal cortices 56 haemodynamic 56 negative affectivity 56 blood Phe levels 56 TT genotype 56 conventional DMARDs 56 mood disorders 56 postoperative pulmonary 56 aMCI 56 cognitively intact 56 VUR 56 comorbid diagnoses 56 elevated creatinine 56 nocturnal enuresis 56 generalized tonic clonic seizures 56 Neuropsychiatric Inventory NPI 56 hypotonia 56 neuroimaging studies 56 premenstrual syndrome PMS 56 hypercoagulable 56 hypopituitarism 56 vagal tone 56 UPDRS motor 56 OAB symptoms 56 CSF biomarkers 56 cerebral infarction 56 intestinal motility 56 Excessive daytime sleepiness 56 perioperative morbidity 56 airway hyperresponsiveness 56 cortical thickness 56 ventricular tachyarrhythmia 56 APOE e4 56 histological subtype 56 suicide ideation 56 chronic prostatitis chronic 56 hepatic lesions 56 biopsychosocial 56 aetiology 56 conditional logistic regression 56 nonadherence 56 externalizing behaviors 56 moderate renal impairment 56 pain catastrophizing 56 hepatocellular 56 impair cognitive 56 untreated celiac disease 56 cytopenias 56 hypercoagulability 56 elevated uric acid 56 C1 INH deficiency 56 dyspnoea 56 mIU L 56 IPAH 56 chromium picolinate supplementation 56 asthma exacerbations 56 nonfasting triglycerides 56 logistic regression analysis 56 HBeAg 56 subclinical disease 56 serotonin signaling 56 late onset hypogonadism 56 Global Impression CGI 56 guideline concordant 56 neuropsychiatric diseases 56 Multiple logistic regression 56 Multivariate analysis 56 plasma pharmacokinetics 56 clinically meaningful improvements 56 Parkinsonian symptoms 56 CVD mortality 56 biochemical abnormalities 56 morphometric vertebral fractures 56 intracranial atherosclerosis 56 interobserver reliability 56 Oppositional Defiant Disorder 56 symptom exacerbation 56 NIHSS score 56 thiopurine 56 coagulopathy 56 co morbidities 56 neuroleptics 56 ejaculatory function 56 perinatal outcomes 56 Hyperactivity 56 nonvertebral fracture 56 amyloid pathology 56 diabetes dyslipidemia 56 Attention Deficit Hyperactive Disorder 56 Alzheimer Disease AD 56 elevated serum ALT 56 G6PD deficiency 56 prodromal 56 Expanded Disability Status 56 urinary oxalate 56 apolipoprotein E4 56 Score DAS 56 hypoglycemic episodes 56 medically unexplained 56 radiographic findings 56 abnormal cytology 56 akathisia 56 Secondhand smoke exposure 56 recurrent acute pancreatitis 56 tHcy 56 socioeconomic variables 56 confusional 56 NIHSS 56 compulsive hoarding syndrome 56 intestinal microflora 56 extrapyramidal side 56 Status Scale EDSS 56 Parkinson Disease PD 56 EGFR mutation status 56 fasting plasma glucose 56 allostatic load 56 serum homocysteine 56 Endothelial dysfunction 56 EORTC QLQ C# 56 Singh Manoux 56 cryptorchidism 56 Diabetic neuropathy 56 plasma triglycerides 56 VaD 56 thyroid hormone levels 56 Primary IGFD 56 aMCI precursor 56 nonexposed 56 glycosylated hemoglobin levels 56 serum GGT 56 hypometabolism 56 unmeasured confounding 56 HbA1C levels 56 cerebellar vermis 56 embolic stroke 56 Rating Scale MADRS 56 cerebral ischemia 56 macrovascular disease 56 glycaemia 56 confounding variables 56 cardiovascular disease hypertension 56 psychosocially 56 P = .# 56 morphological abnormalities 56 folate deficiency 56 prothrombotic 56 macroalbuminuria 56 psychotic disorders 56 penile erection 56 perfusion abnormalities 56 plasma adiponectin 56 hemodilution 56 Autistic Disorder 56 adjunctive ABILIFY 56 Disordered eating 56 macrovascular complications 56 Fibromyalgia Impact Questionnaire 56 fatty acid oxidation 56 neurocognitive disorder 56 adenoma recurrence 56 borderline personality disorder 56 postoperative mortality 56 RLS symptoms 56 recurrent venous thromboembolism 56 Obsessive compulsive disorder OCD 56 carotid stenosis 56 hepatic cirrhosis 56 dopamine D2 receptors 56 urinary bowel 56 neurobiological basis 56 CR nPR 56 manic hypomanic 56 carotid bruit 55 systemic corticosteroid 55 temporal lobectomy 55 plasma homocysteine levels 55 asplenia 55 paraneoplastic 55 Subgroup analyzes 55 highly heritable 55 Distress Scale 55 Prehypertension 55 serum cholesterol 55 Erythropoietic therapies may 55 detrusor 55 periprocedural MI 55 Adjuvant chemotherapy 55 Pathological gambling 55 alanine aminotransferase 55 dietary folate 55 glycemia 55 NNT = 55 = #.#-#.# 55 impulsive behaviors 55 leptin deficiency 55 metabolic dysregulation 55 psychophysiological 55 antipsychotic induced 55 familial hypercholesterolemia 55 serum lipids 55 nonischemic 55 cognitive perceptual 55 EDSS score 55 fasting glucose levels 55 frontal lobe dysfunction 55 gastrointestinal dysfunction 55 tertiles 55 lamotrigine 55 diastolic pressures 55 hormonal deficiencies 55 confounder 55 SIADH 55 urinary excretion 55 pelvic lymphadenectomy 55 hematologic parameters 55 inflammatory markers 55 intracranial stenosis 55 parenchymal 55 hydrops 55 GH deficient 55 analgesic medications 55 ventricular remodeling 55 cardiac malformations 55 recurrent miscarriage 55 neurologic deficits 55 thyroid deficiency 55 antisocial traits 55 Negative Syndrome 55 CI -#.# 55 gastro oesophageal reflux 55 somatization 55 tryptophan depletion 55 AGILECT R 55 hyperalgesia 55 socioeconomic deprivation 55 Alzheimer Disease Assessment 55 sexual dysfunctions 55 MTHFD1L gene 55 vessel dilation 55 QTc intervals 55 insulin sensitizing drug 55 β amyloid 55 hepatic fibrosis 55 cross sectionally 55 Logistic regression 55 arterial thromboembolic events 55 N acetylaspartate 55 EBV infection 55 ventral prefrontal cortex 55 symptomology 55 baroreflex sensitivity 55 Kaplan Meier curve 55 Conduct Disorder 55 repolarization 55 intraventricular hemorrhage 55 polyp recurrence 55 oral anticoagulant therapy 55 mild cognitive impairments 55 PLX STROKE targeting 55 intracerebral haemorrhage 55 NNRTI resistance 55 HOMA IR 55 EXJADE 55 orbitofrontal 55 testosterone supplementation 55 platelet inhibition 55 thrombotic complications 55 FeNO 55 extensive metabolizers 55 inhibitory neurotransmitters 55 serum calcium 55 STEP BD 55 hirsutism 55 psychomotor skills 55 depressive illnesses 55 depression suicidal thoughts 55 hypothalamic pituitary adrenal HPA 55 structural abnormalities 55 tumor histology 55 triiodothyronine 55 hematological parameters 55 virologic responses 55 perimenopausal women 55 clinically meaningful improvement 55 blood glucose concentrations 55 orthostatic 55 fatty infiltration 55 recurrent wheezing 55 serum urate levels 55 bivariate 55 amenorrhoea 55 bronchopulmonary dysplasia 55 arterial calcification 55 vitreous floaters 55 tissue oxygenation 55 psychopathic traits 55 ABCB1 55 atrophic gastritis 55 apneic episodes 55 urinary N telopeptide 55 nasal obstruction 55 postural sway 55 Exclusion criteria 55 underdiagnosis